Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2011 R21 RFA-CA-10-005 CLARY, BRYAN M DUKE UNIVERSITY IN VIVO SELECTION OF TUMOR-SPECIFIC RNA BINDING MOTIFS Complete
2018 R21 RFA-CA-17-012 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome NCE
1999 R21 PAR-98-067 STRAUSS, WILLIAM M BETH ISRAEL DEACONESS MEDICAL CENTER EVALUATION OF SEQUENCE SPECIFIC CHANGES IN GENOMIC DNA Complete
2007 R21 RFA-CA-07-002 KAUFMAN, DAVID G. UNIV OF NORTH CAROLINA CHAPEL HILL IDENTIFICATION OF AREAS OF OXIDATIVE DAMAGE IN HUMAN GENOMIC DNA Complete
2006 R21 RFA-CA-06-003 SHI, HUIDONG UNIVERSITY OF MISSOURI-COLUMBIA EPIGENETIC TARGETING IN NON-HODGKIN'S LYMPHOMA Complete
2009 R21 RFA-CA-08-006 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROASSAY SYSTEMS FOR DIAGNOSIS OF CANCER CELL MOTILITY AND METASTASIS Complete
2016 R21 RFA-CA-15-002 LIANG, FU-SEN UNIVERSITY OF NEW MEXICO NOVEL BI-FUNCTIONAL INHIBITORS BLOCKING ONCOMIR BIOGENESIS Complete
2000 R21 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2008 R21 RFA-CA-07-037 YANNELLI, JOHN R. UNIVERSITY OF KENTUCKY CRYOPREPARATION OF PBMC FOR IMMUNOTHERAPY AND IMMUNE ASSESSMENT STUDIES. Complete
2011 R21 RFA-CA-10-005 RAO, JIANGHONG STANFORD UNIVERSITY NANOTECHNOLOGY FOR MULTIPLEX DETECTION OF ENZYMES Complete
2018 R21 RFA-CA-17-012 SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN WAKE FOREST UNIVERSITY HEALTH SCIENCES Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids Active
1999 R21 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2007 R21 RFA-CA-07-002 COOPER, LAURENCE J.N. UT MD ANDERSON CANCER CTR UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY Complete
2006 R21 RFA-CA-06-004 O'LEARY, TIMOTHY J. AMERICAN REGISTRY OF PATHOLOGY, INC. RECOVERY OF RNA FROM FORMALIN-FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY HIGH-THROUGHPUT INTRACELLULAR MICRORHEOLOGY: A NEW TOOL FOR CANCER RESEARCH Complete
2016 R21 RFA-CA-15-002 MATOUSCHEK, ANDREAS UNIVERSITY OF TEXAS, AUSTIN DEVELOPMENT OF PROTEASOME ADAPTORS TO CATALYTICALLY DEPLETE SPECIFIC PROTEINS FROM CELLS Complete
2000 R21 PAR-99-100 STANTON, MARTIN J BRANDEIS UNIVERSITY APTAMER BASED DETECTOR TO QUANTIFY MACROMOLECULES Complete
2008 R21 RFA-CA-07-037 WEIER, HEINZ-ULRICH GUENTER UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB ACCELERATING CANCER RESEARCH WITH SINGLE CELL ARRAYS Complete
2011 R21 RFA-CA-10-005 LAWRENCE, DAVID A WADSWORTH CENTER HOLISTIC DIAGNOSTICS OF HOST DURING DEVELOPMENT OF CANCER Complete
1999 R21 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete
2007 R21 RFA-CA-07-002 KERR, WILLIAM GARROW H. LEE MOFFITT CANCER CTR & RES INST DEFINING THE MULTIPLE MYELOMA KINOME Complete
2017 R21 RFA-CA-16-001 WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Single-molecule counting of cancer biomarker miRNAs in human biofluids Complete
2006 R21 RFA-CA-06-004 JU, JINGFANG UNIVERSITY OF SOUTH ALABAMA NOVEL METHOD FOR ISOLATING ACTIVELY TRANSLATED MRNAS Complete
2009 R21 RFA-CA-08-006 KANDEL, EUGENE S ROSWELL PARK CANCER INSTITUTE CORP ARRAY-ASSISTED INSERTIONAL MUTAGENESIS FOR MOLECULAR ANALYSIS OF CANCER Complete
2013 R21 RFA-CA-12-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV SENSITIVE AND INTEGRATED MICROFLUIDIC CHIP ASSAYS FOR STUDYING TRANSCRIPTIONAL RE Complete
2016 R21 RFA-CA-15-002 RECHT, MICHAEL PALO ALTO RESEARCH CENTER HIGH-THROUGHPUT SCREENING PLATFORM FOR CANCER DRUG DISCOVERY Complete
2000 R21 PAR-99-102 GRIFFITH, JEFFREY K UNIVERSITY OF NEW MEXICO PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY Complete
2008 R21 RFA-CA-07-037 KNUDSEN, BEATRICE S FRED HUTCHINSON CANCER RESEARCH CENTER TISSUE LYSATES FOR STUDIES OF PROTEIN PHOSPHORYLATION Complete
2011 R21 RFA-CA-10-005 SHENDURE, JAY ASHOK UNIVERSITY OF WASHINGTON ULTRASENSITIVE IDENTIFICATION AND PRECISE QUANTITATION OF LOW FREQUENCY SOMATIC M Complete
2002 R21 PAR-01-104 YEUNG, EDWARD S. IOWA STATE UNIVERSITY SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING Complete
1999 R21 PAR-98-067 VIDAL, MARC MASSACHUSETTS GENERAL HOSPITAL NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING Complete
2007 R21 RFA-CA-07-002 GARRAWAY, LEVI ALEXANDER DANA-FARBER CANCER INST HIGH-THROUGHPUT ONCOGENE MUTATION DETECTION IN HUMAN CANCER Complete
2017 R21 RFA-CA-16-001 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA A Target-Directed Reagent Pipeline via Microfluidic mRNA Display NCE
2006 R21 RFA-CA-06-004 HSI, ERIC CLEVELAND CLINIC LERNER COL/MED-CWRU CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES Complete
2009 R21 RFA-CA-08-006 MC GOWN, LINDA B. RENSSELAER POLYTECHNIC INSTITUTE HYBRIDIZATION OF PROMOTER DNA TARGETS IN CHROMATIN TO DISCOVER REGULATORY PROTEIN Complete
2013 R21 RFA-CA-12-002 CASTRO, CARLOS E. OHIO STATE UNIVERSITY NANOSCALE TOOLS FOR FUNCTIONAL STUDIES OF CANCER-RELEVANT CHROMATIN MODIFICATIONS Complete
2016 R21 RFA-CA-15-002 SADEGHI , SAMAN UNIVERSITY OF CALIFORNIA LOS ANGELES ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS Complete
2000 R21 PAR-99-102 OH, SEAJIN SRI INTERNATIONAL AFM BASED TECHNIQUE--ANALYZES EXPRESSION IN CANCER CELLS Complete
2011 R21 RFA-CA-10-005 HUANG, SONGPING D KENT STATE UNIVERSITY AT KENT PRUSSIAN BLUE NANOPARTICLES AS CELLULAR T1 MRI CONTRAST AGENTS Complete
2002 R21 PAR-01-104 KNAPP, DANIEL R. MEDICAL UNIVERSITY OF SOUTH CAROLINA MICROFLUIDIC SYSTEM FOR CANCER PROTEOME ANALYSIS Complete
2005 R21 RFA-CA-05-002 WYMAN, ROBERT J YALE UNIVERSITY GENETIC METHODS FOR DETECTING GAP JUNCTION COMMUNICATION Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2007 R21 RFA-CA-07-002 SEGALL, JEFFREY E ALBERT EINSTEIN COLLEGE OF MEDICINE DEVELOPMENT OF AN IN VIVO METASTASIS SCREEN Complete
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing Active
2006 R21 RFA-CA-06-004 COTE, RICHARD JAMES UNIVERSITY OF SOUTHERN CALIFORNIA INTEGRATED MICRODEVICE TO CAPTURE AND DETECT CIRCULATING TUMOR CELLS Complete
2009 R21 RFA-CA-08-006 CHAREST, JOSEPH LEO CHARLES STARK DRAPER LABORATORY MICROFLUIDIC 3D SCAFFOLD ASSAY FOR CANCER CELL MIGRATION AND INTRAVASATION Complete
2013 R21 RFA-CA-12-002 BAI, MINGFENG UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NOVEL THERANOSTIC PLATFORM FOR TARGETED CANCER THERAPY AND TREATMENT MONITORING Complete
2016 R21 RFA-CA-15-002 SEGAL, DAVID J UNIVERSITY OF CALIFORNIA AT DAVIS CRISPR-BASED EPIGENETIC MODIFIERS Complete
2000 R21 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2002 R21 PAR-01-104 HEYDUK, TOMASZ SAINT LOUIS UNIVERSITY MOLECULAR BEACONS FOR PROTEIN DETECTION Complete

Pages